Back
Revance Therapeutics Quote, Financials, Valuation and Earnings
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
33
RVNC
Revance Therapeutics
Last Price:
3.78
Seasonality Move:
2.55%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right hereRevance Therapeutics Price Quote
$3.78
+0.00 (+-0.26%)
(Updated: May 3, 2024 at 5:36 AM ET)
Revance Therapeutics Key Stats
Sell
33
Revance Therapeutics (RVNC)
is a Sell
Day range:
$3.66 - $3.99
52-week range:
$3.21 - $37.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.36
P/B ratio:
0%
Volume:
1.1M
Avg. volume:
1.7M
1-year change:
-88.61%
Market cap:
$393.4M
Revenue:
$234M
EPS:
$-3.8
How Much Does Revance Therapeutics Make?
-
How Much Are Revance Therapeutics's Sales Annually?
RVNC Revenues are $234M -
How Much Profit Does Revance Therapeutics's Make A Year?
RVNC net income is -$324M
Is Revance Therapeutics Growing As A Company?
-
What Is Revance Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.4% -
What Is Revance Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Revance Therapeutics Stock Price Performance
-
Did Revance Therapeutics Stock Go Up Last Month?
Revance Therapeutics share price went down by -16.3% last month -
Did RVNC's Share Price Rise Over The Last Year?
RVNC share price fell by -88.61% over the past 1 year
What Is Revance Therapeutics 52-Week High & Low?
-
What Is Revance Therapeutics’s 52-Week High Share Price?
Revance Therapeutics has traded as high as $37.98 over the past 52 weeks -
What Is Revance Therapeutics’s 52-Week Low Share Price?
Revance Therapeutics has traded as low as $3.21 over the past 52 weeks
Revance Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Revance Therapeutics?
-
How Much Debt Does Revance Therapeutics Have?
Total long term debt quarterly is $429.1M -
How Much Cash Does Revance Therapeutics Have?
Cash and short term investments quarterly total is $253.9M -
What Is Revance Therapeutics’s Book Value Per Share?
Book value per share is -1.72
Is Revance Therapeutics Cash Flow Positive?
-
What Is RVNC Cash Flow From Operations?
Cash flow from operations (TTM) is -$216.6M -
What Is Revance Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $136.6M -
What Is Revance Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $109.7M
Revance Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
RVNC return on invested capital is -92.45% -
What Is Revance Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -59.15% -
What Is RVNC Return On Equity?
ROE is a measure of profitability and is 0%
Revance Therapeutics Earnings Date & Stock Price
-
What Is Revance Therapeutics's Stock Price Today?
A single share of RVNC can be purchased today for 3.78 -
What Is Revance Therapeutics’s Stock Symbol?
Revance Therapeutics trades on the nasdaq under the ticker symbol: RVNC -
When Is Revance Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Revance Therapeutics is scheduled on May 9, 2024 -
When Is RVNC's next ex-dividend date?
Revance Therapeutics's next ex-dividend date is May 15, 2020 -
How To Buy Revance Therapeutics Stock?
You can buy Revance Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Revance Therapeutics Competitors
-
Who Are Revance Therapeutics's Competitors?
Below is a list of companies who compete with Revance Therapeutics or are related in some way:
Revance Therapeutics Dividend Yield
Data Unavailable
Revance Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 33.86% |
| Revenue: | 39.82% | 12.4% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 16.33 |
| Upside from Last Price: | 332.67% |